EA200300231A1 - TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA - Google Patents

TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA

Info

Publication number
EA200300231A1
EA200300231A1 EA200300231A EA200300231A EA200300231A1 EA 200300231 A1 EA200300231 A1 EA 200300231A1 EA 200300231 A EA200300231 A EA 200300231A EA 200300231 A EA200300231 A EA 200300231A EA 200300231 A1 EA200300231 A1 EA 200300231A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compound
tiazolidindiona
tartrat
salts derivative
derivative
Prior art date
Application number
EA200300231A
Other languages
Russian (ru)
Inventor
Эндрю Саймон Крейг
Тим Чиен Тинг Хо
Майкл Миллан
Original Assignee
Смитклайн Бичам П.Л.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Смитклайн Бичам П.Л.С. filed Critical Смитклайн Бичам П.Л.С.
Publication of EA200300231A1 publication Critical patent/EA200300231A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4406—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 3, e.g. zimeldine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Neurology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Cosmetics (AREA)

Abstract

Настоящее изобретение относится к новому фармацевтическому соединению мезо-тартрат 5-[4-[2-(N-метил-N-(2-пиридил)амино)этокси]бензил]тиазолидин-2,4-диона или его сольвату, способу получения такого соединения, фармацевтической композиции, содержащей такое соединение, и применению такого соединения в медицине.Международная заявка была опубликована вместе с отчетом о международном поиске.The present invention relates to a 5- [4- [2- (N-methyl-N- (2-pyridyl) amino) ethoxy] benzyl] thiazolidine-2,4-dione meso-tartrate pharmaceutical compound, or a method for the production of a compound, a pharmaceutical composition containing such a compound, and the use of such a compound in medicine. The international application was published with an international search report.

EA200300231A 2000-08-04 2001-08-03 TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA EA200300231A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0019226.0A GB0019226D0 (en) 2000-08-04 2000-08-04 Novel pharmaceutical
PCT/GB2001/003514 WO2002012233A1 (en) 2000-08-04 2001-08-03 Tartrate salts of thiazolidinedione derivative

Publications (1)

Publication Number Publication Date
EA200300231A1 true EA200300231A1 (en) 2003-06-26

Family

ID=9897028

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200300231A EA200300231A1 (en) 2000-08-04 2001-08-03 TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA

Country Status (23)

Country Link
EP (1) EP1307448A1 (en)
JP (1) JP2004505971A (en)
KR (1) KR20030022356A (en)
CN (1) CN1458930A (en)
AP (1) AP2003002737A0 (en)
AU (1) AU2001276508A1 (en)
BG (1) BG107605A (en)
BR (1) BR0112984A (en)
CA (1) CA2417828A1 (en)
CZ (1) CZ2003314A3 (en)
EA (1) EA200300231A1 (en)
EC (1) ECSP034468A (en)
GB (1) GB0019226D0 (en)
HU (1) HUP0300770A2 (en)
IL (1) IL154277A0 (en)
MA (1) MA25830A1 (en)
MX (1) MXPA03001086A (en)
NO (1) NO20030508L (en)
OA (1) OA12355A (en)
PL (1) PL360702A1 (en)
SK (1) SK1452003A3 (en)
WO (1) WO2002012233A1 (en)
ZA (1) ZA200300962B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
FR2845602B1 (en) * 2002-10-11 2005-07-08 Servier Lab ASSOCIATION BETWEEN A LIGAND OF RECEPTORS ACTIVE BY PEROXISOME PROLIFIERS AND AN ANTIOXIDANT AGENT AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US7264813B2 (en) 2003-09-24 2007-09-04 Nikken Sohonsha Corporation Therapeutic uses of Dunaliella powder
CN102532122B (en) * 2010-12-29 2015-12-02 开封制药(集团)有限公司 The preparation method of Tartraric rosiglitazone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
MA25830A1 (en) 2003-07-01
KR20030022356A (en) 2003-03-15
ZA200300962B (en) 2003-10-29
NO20030508L (en) 2003-03-20
BG107605A (en) 2003-09-30
CN1458930A (en) 2003-11-26
EP1307448A1 (en) 2003-05-07
GB0019226D0 (en) 2000-09-27
WO2002012233A1 (en) 2002-02-14
AU2001276508A1 (en) 2002-02-18
CZ2003314A3 (en) 2004-02-18
MXPA03001086A (en) 2003-05-27
OA12355A (en) 2004-03-19
HUP0300770A2 (en) 2003-11-28
CA2417828A1 (en) 2002-02-14
ECSP034468A (en) 2003-03-31
JP2004505971A (en) 2004-02-26
IL154277A0 (en) 2003-09-17
PL360702A1 (en) 2004-09-20
BR0112984A (en) 2003-06-10
NO20030508D0 (en) 2003-01-31
AP2003002737A0 (en) 2003-03-31
SK1452003A3 (en) 2004-05-04

Similar Documents

Publication Publication Date Title
EA200200975A1 (en) HYDROCHLORIDE 5- [4- [2- (N-METHYL-N- (2-Pyridyl) AMINO) ETOXY] BENZYL] THIAZOLIDIN-2,4-DIONA
CY1106226T1 (en) 5-[4-[2-(N-METHYL-N-(2-PYRIDYL)AMINO)ETHOXY]BENZYL]THIAZOLIDINO-2,4-DIONE MESYLATE SALT
CY1105252T1 (en) 5-[4-[2-(N-METHYLO-N-(2-PYRIDYL)AMINO)-ETHOXY]BENZYL]THIAZOLIDINO-2,4-DIONE HYDROCHLORIDE SALT
EA200300234A1 (en) TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA
EA200300231A1 (en) TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA
CY1105354T1 (en) A THIAZOLIDINODIONE DERIVATIVE AND ITS USE AS AN ANTI-DIABETIC
EA200300230A1 (en) TRAT SALT DERIVATIVE TIAZOLIDINDIONA
EA200300005A1 (en) SALT THIAZOLIDINDION FOR THE TREATMENT OF DIABETES MELLITUS
PT1446404E (en) EDISILATES OF ROSIGLITAZONE AND ITS USE AS ANTIDIABETICS
EA200300232A1 (en) TARTRAT SALTS DERIVATIVE TIAZOLIDINDIONA
EA200101102A1 (en) NEW PHARMACEUTICAL PREPARATION
EA200300422A1 (en) SODIUM SALTS 5- [4- [2- (N-METHYL-N- (2-Pyridyl) AMINO) ETOXY] BENZYL] THIAZOLIDIN-2,4-DIONA
EA200300004A1 (en) HYDROIODID 5- [4- [2- (N-METHYL-N- (2-Pyridyl) AMINO) ETOXY] BENZYL] THIAZOLIDIN-2,4-DIONA AS PHARMACEUTICAL PREPARATION
EA200300423A1 (en) TIAZOLIDINDION DERIVATIVE AND ITS APPLICATION AS AN ANTI-DIABETIC MEDICINE
HK1068884A1 (en) 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt